Back

Gin Hwa Biotech to list in October at NT$52 as 2026 profit declines

Verifying
  • Gin Hwa Biotech is set to list on the Taipei Exchange in mid-October.
  • First-half net profit fell 40.97% year-over-year to NT$28.29 million.
  • The company expects its second plant to be completed in 2027.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.